BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8286986)

  • 21. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
    Brown M; Noursadeghi M; Boyle J; Davidson RN
    Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of lethal effect of human serum upon Leishmania donovani.
    Pearson RD; Steigbigel RT
    J Immunol; 1980 Nov; 125(5):2195-201. PubMed ID: 7430624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
    Kretschmar M; Nichterlein T; Hannak D; Hof H
    Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of a kaurenic acid extracted from the Venezuelan plant Wedelia trilobata (Asteracea) against Leishmania (Viannia) braziliensis].
    Brito S; Crescente O; Fernández A; Coronado A; Rodriguez N
    Biomedica; 2006 Oct; 26 Suppl 1():180-7. PubMed ID: 17361853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin B both inhibits and enhances T-cell proliferation: inhibitory effect is mediated through H(2)O(2) production via cyclooxygenase pathway by macrophages.
    Kumar S; Chakrabarti R
    J Cell Biochem; 2000 Apr; 77(3):361-71. PubMed ID: 10760945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione in the cellular defense of human lung cells exposed to hyperoxia and high pressure.
    Djurhuus R; Svardal AM; Thorsen E
    Undersea Hyperb Med; 1999; 26(2):75-85. PubMed ID: 10372426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High purity amphotericin B.
    Cleary JD; Chapman SW; Swiatlo E; Kramer R
    J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lidocaine pharmacokinetics during hyperbaric hyperoxia in humans.
    Rump AF; Siekmann U; Fischer DC; Kalff G
    Aviat Space Environ Med; 1999 Aug; 70(8):769-72. PubMed ID: 10447050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro reversible transformation of Leishmania braziliensis panamensis between promastigote and ellipsoidal forms.
    Darling TN; Blum JJ
    J Protozool; 1987 May; 34(2):166-8. PubMed ID: 3585815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
    Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphotericin-B-loaded polymer-functionalized reduced graphene oxides for Leishmania amazonensis chemo-photothermal therapy.
    Vitorino LS; Dos Santos TC; Bessa IAA; Santos ECS; Verçoza BRF; de Oliveira LAS; Rodrigues JCF; Ronconi CM
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112169. PubMed ID: 34752985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells.
    Reyes E; Cardona J; Prieto A; Bernstein ED; Rodríguez-Zapata M; Pontes MJ; Alvarez-Mon M
    J Infect Dis; 2000 Jun; 181(6):2003-10. PubMed ID: 10837182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
    An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
    Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitative evaluation and prognosis of the biological effects of hyperoxia].
    Filatov AV; Leonov AN; Reznikov KM; Chernykh IK
    Fiziol Zh SSSR Im I M Sechenova; 1985 Mar; 71(3):328-32. PubMed ID: 3996661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of the effect of phenazine methosulfate and vitamin K3 on human erythrocytes by hemolysis curves].
    Kaĭrakbaeva GM; Toktamysova ZS
    Biofizika; 1991; 36(6):1048-50. PubMed ID: 1809383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in the oxygen tension of rat cerebral cortex subsequent to hyperoxia and the protective effect of urea].
    Kartashev IP; Titov VV
    Fiziol Zh SSSR Im I M Sechenova; 1976 Jul; 62(7):1062-7. PubMed ID: 955149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential effect of liposomal amphotericin B on human erythrocytes and promastigotes of Leishmania sp.
    Ramos H; Romero E; Cohen BE
    Acta Cient Venez; 1988; 39(2):135-9. PubMed ID: 3251381
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of hyperoxia and physical exercise on *OH-radical stress in humans as measured by dihydroxylated benzoates (DHB) in urine.
    Kähler W; Koch I; Wohlrab C; Kowalski J; Witte J; Koch A
    Undersea Hyperb Med; 2013; 40(3):231-8. PubMed ID: 23789558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.